-
1
BCMA CAR-T therapy as salvage therapy in patients with plasmablastic myeloma
Published 2025-12-01Subjects: Get full text
Article -
2
-
3
Knockout IL4I1 affects macrophages to improve poor efficacy of CD19 CAR-T combined with PD-1 inhibitor in relapsed/refractory diffuse large B-cell lymphoma
Published 2025-01-01Subjects: “…CD19 CAR-T…”
Get full text
Article -
4
Treatment of pro-B acute lymphoblastic leukemia and severe plaque psoriasis with anti-CD19 CAR T cells: a case report
Published 2025-03-01Subjects: Get full text
Article -
5
Inotuzumab Ozogamicin as a Bridge to Stem Cell Transplantation in Relapsed Pediatric BCP‐ALL After Tisagenlecleucel: A Case Series
Published 2025-03-01Subjects: “…anti‐CD19 CAR T‐cell therapy…”
Get full text
Article -
6
CD19 CAR-T cell therapy: a new dawn for autoimmune rheumatic diseases?
Published 2024-12-01Subjects: “…CD19 CAR-T…”
Get full text
Article -
7
Hypoimmunogenic CD19 CAR-NK cells derived from embryonic stem cells suppress the progression of human B-cell malignancies in xenograft animals
Published 2024-11-01Subjects: Get full text
Article -
8
A preclinical study of allogeneic CD19 chimeric antigen receptor double‐negative T cells as an off‐the‐shelf immunotherapy drug against B‐cell malignancies
Published 2024-01-01Subjects: “…allogeneic CD19‐CAR‐DNTs…”
Get full text
Article -
9
Engineering safe anti-CD19-CD28ζ CAR T cells with CD8a hinge domain in serum-free media for adoptive immunotherapy
Published 2025-05-01Subjects: “…CD19 CAR T cells…”
Get full text
Article -
10
A long-term survivor of congenital KMT2A-R B-lymphoblastic leukemia with persistently positive bone marrow MRD and multiple CNS relapses
Published 2025-02-01Subjects: Get full text
Article -
11
Case Report: Remission of a patient with complex combination of autoimmune diseases by anti-CD19 CAR-T cell therapy
Published 2025-08-01Subjects: Get full text
Article -
12
CAR-NK cell therapy: promise and challenges in solid tumors
Published 2025-04-01Subjects: Get full text
Article -
13
Incidentally cured psoriasis in a patient with refractory/relapsed diffuse large B-cell lymphoma receiving CD19 CAR-T cell therapy: a case report
Published 2024-10-01Subjects: Get full text
Article -
14
Anti-CD19 CAR-T cell therapy in relapsed/refractory t(8;21) acute myeloid leukemia with aberrant CD19 expression
Published 2025-07-01Subjects: Get full text
Article